Medlab Clinical Limited filed its F-1 on Oct 13, 2022 for the period ending Jun 30, 2022. In this report its auditor, Accell Audit & Compliance, P.A, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% | -5.04% | -.--% |
May. 15 | Medlab Clinical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Apr. 24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 10.01M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MDC Stock
- News Medlab Clinical Limited
- Medlab Clinical Limited Auditor Raises 'Going Concern' Doubt